Eating leafy greens ‘associated with fewer brain proteins linked to Alzheimer’s’ The study involved 581 people who followed the MIND and Mediterranean diets. The Independent UK · Mar 8, 2023
Research: Alzheimer's development linked to cholesterol, toxic protein clusters Texas A&M's College of Agriculture and Life Sciences researchers discovered that cholesterol significantly boosts the toxicity of a peptide linked to the advancement of Alzheimer's disease. Read further on Dynamite News: Dynamite News · Mar 5, 2023
Dementia-related pain: What caregivers need to know Dementia isn't a specific disease. Instead, it describes a collection of symptoms that affect a person's thinking and social abilities enough to interfere with daily life. There are more than 55 million people worldwide living with dementia. Of these, 50% to 60% have Alzheimer's disease. Dementia is the seventh leading… Tribune News Service · Feb 27, 2023
Teenager’s ‘probable’ Alzheimer’s diagnosis baffles scientists Patient has trouble studying and was forced to withdraw from high school The Independent UK · Feb 24, 2023
A 19-year-old is the youngest person to be diagnosed with Alzheimer's disease – the cause is a mystery A 19-year-old man from China, who has been having memory problems since the age of 17, was diagnosed with dementia, according to a recent case study published in the Journal of Alzheimer’s Disease. The Conversation · Feb 22, 2023
What is frontotemporal degeneration? Frontotemporal degeneration (FTD) is a group of neurologic disorders associated with changes in personality, behavior, language or movement. Some FTD forms are inherited, and some are not. Typically, people develop FTD symptoms before age 60. Tribune News Service · Feb 17, 2023
Researchers find similar brain pattern shifts in two common conditions A new study finds changes in the brain associated with obesity overlap with similar patterns seen in Alzheimer's disease. Inverse · Feb 8, 2023
Study: Weight Loss Can Be Early Predictor Of Alzheimer's Disease In People With Down Syndrome Researchers revealed that unintentional weight loss in individuals with Down syndrome may signal the beginning of Alzheimer's disease long before usual cognitive symptoms like memory loss and dementia become apparent. Read further on Dynamite News: Dynamite News · Feb 4, 2023
Viruses can speed up unhealthy brain aging — vaccines may offer peace of mind There is currently no cure for dementia, but getting vaccinated for common viral illnesses may reduce your risk. Inverse · Jan 28, 2023
New blood test could predict Alzheimer’s 3.5 years before disease Researchers say the test could help ‘predict onset of disease early in a non-invasive fashion’ Evening Standard · Jan 27, 2023
New blood test could detect Alzheimer’s disease years before diagnosis Research supports idea that components in human blood can influence formation of new brain cells The Independent UK · Jan 27, 2023
New blood test could detect Alzheimer’s disease 3.5 years before diagnosis – study Research supports idea that components in human blood can influence formation of new brain cells The Independent UK · Jan 27, 2023
New test 'could detect Alzheimer’s disease 3.5 years before diagnosis' Researchers establish a blood-based test that could predict risk of the condition at an earlier stage Wales Online · Jan 27, 2023
New test could detect Alzheimer’s disease 3.5 years before diagnosis – study The research supports the idea that components in human blood can influence the formation of new brain cells. The Independent UK · Jan 27, 2023
The Conversation · Jan 25, 2023 Possible link between Alzheimer's disease and gut microbiome found in mice – new study Researchers may have found an unlikely contributor to the development of Alzheimer’s disease: the bacteria in your gut. Their study, published in the journal Science, suggested that certain gut bacteria increase the brain damage seen in mice with an Alzheimer’s-like disease.
The Conversation · Jan 18, 2023 Alzheimer's: blood biomarker may help identify the disease ten years before symptoms start Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition – and treatment options are limited.
The Conversation · Jan 18, 2023 Vaccination to prevent dementia? New research suggests one way viral infections can accelerate neurodegeneration One in nine Americans ages 65 and over had Alzheimer’s disease in 2022, and countless others were indirectly affected as caregivers, health care providers and taxpayers. There is currently no cure – available treatments primarily focus on prevention by encouraging protective factors, such as exercise and healthy diet, and reducing…
The Guardian - UK · Jan 14, 2023 HRT ‘potentially important’ in reducing women’s dementia risk Research suggests hormone replacement therapy may reduce risk of Alzheimer’s in some women
The Conversation · Jan 13, 2023 What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.
Tribune News Service · Jan 10, 2023 Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.
Dynamite News · Dec 28, 2022 New Biomarker Test Can Identify Alzheimer's Neurodegeneration In Blood: Study A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration. Read on for details:
The Independent UK · Dec 28, 2022 New blood test developed to detect signs of Alzheimer’s disease ‘A blood test is cheaper, safer and easier to administer, and it can improve clinical confidence in diagnosing Alzheimer’s’
Dynamite News · Dec 26, 2022 Traumatic Brain Injury, PTSD Associated With Alzheimer's: Research The medical profession has never before investigated the effects of traumatic brain injury (TBI), post-traumatic stress disorder (PTSD) and genetic risk factors in a sizable cohort. Read on for details:
ABC News · Dec 22, 2022 Researchers find signs of Alzheimer's disease in dolphins Researchers in Scotland have found dolphins with classic markers of Alzheimer's disease in their brains, potentially pointing to the reason the animals became stranded.
The Conversation · Dec 21, 2022 Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease On Nov. 30, Eisai and Biogen announced the results of their latest phase 3 clinical trial in Alzheimer’s disease. The verdict: an 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The study…